Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.1188
Delayed Data
As of Sep 26
 -0.0041 / -3.34%
Today’s Change
0.11
Today|||52-Week Range
0.53
-66.56%
Year-to-Date
5 Biotech Stocks That Are Broker Favorites
Sep 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.12
Today’s open0.12
Day’s range0.12 - 0.12
Volume1,788,999
Average volume (3 months)2,091,610
Market cap$15.7M
Dividend yield--
Data as of 4:02pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...0.000.00%
HTGMHTG Molecular Diagno...-0.02-0.80%
BASIBioanalytical System...+0.02+1.74%
FSIFlexible Solutions I...+0.07+3.26%
Data as of 3:57pm ET, 09/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts

Search for Jobs